Post Marketing Surveillance to Collect and Evaluate the Safety and Efficacy Information of Korean MDS Patients Treated With VIDAZA®, After Approval of Marketing Authorization for New Drug in Korea

NCT02137629 · clinicaltrials.gov ↗
COMPLETED
Status
511
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celgene